Back to Search
Start Over
Rimonabant for overweight and "metabolic syndrome": the attempt to supersize disease and risk by pharmaceutical marketing.
- Source :
-
Internal and emergency medicine [Intern Emerg Med] 2008 Mar; Vol. 3 (1), pp. 53-6. Date of Electronic Publication: 2008 Mar 04. - Publication Year :
- 2008
Details
- Language :
- English
- ISSN :
- 1828-0447
- Volume :
- 3
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Internal and emergency medicine
- Publication Type :
- Academic Journal
- Accession number :
- 18317866
- Full Text :
- https://doi.org/10.1007/s11739-008-0139-x